Brothers Healthcare, Inc. v. Brian Carter, Inc.

District Court, D. Hawaii·Decided August 30, 2022·No. 1:21-cv-00383·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF HAWAI‘I BROTHERS HEALTHCARE, INC., Case No. 21-cv-00383-DKW-RT

Plaintiff, ORDER GRANTING IN PART AND DENYING IN PART v. DEFENDANT’S MOTION FOR JUDGMENT ON THE BRIAN CARTER, INC., PLEADINGS WITH LEAVE TO d/b/a Westside Specialty Pharmacy, et al., AMEND

Defendants.

Defendant Brian Carter, Inc. (Carter) moves for judgment in this lawsuit premised upon a business relationship with Plaintiff Brothers Healthcare, Inc. (Brothers) that appears to have soured. Brothers alleges that the parties agreed to provide pharmacy services to Brothers’ patients, but, instead of acting consistent with their agreement to accomplish this goal, Carter chose to essentially steal some of Brothers’ patients and at least one of Brothers’ employees and failed to pay Brothers as they had agreed. Carter argues that all claims related to these allegations should be dismissed primarily because Brothers has failed to allege sufficient facts to support plausible claims for relief under Ashcroft v. Iqbal, 556 U.S. 662 (2009) and Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007). Having reviewed the parties’ briefing and the Complaint, the Court, in part, agrees with Carter that certain of Brothers’ factual allegations fail to state plausible claims for relief. However, in other respects, Carter’s arguments fail to convince the Court that it is entitled to judgment on the pleadings. Therefore, as more fully

explained below, the motion for judgment on the pleadings, Dkt. No. 28, is GRANTED IN PART and DENIED IN PART with leave to amend the claims that are found deficient.

FACTUAL BACKGROUND The following relevant facts are alleged in the Complaint. In January 2020, Brothers and Carter entered into a Pharmacy Wholesale and Shared Pharmacy Services Patient Care Coordination Agreement (Agreement) for the purpose of

distributing “shared pharmacy services” to Brothers’ patients with bleeding disorders. Compl. at ¶ 6, Dkt. No. 1. Pursuant to the Agreement, the parties intended to provide “shared pharmacy services” as follows. First, Brothers would

receive an initial patient prescription from a patient or prescribing physician. Id. at ¶ 7. Second, Brothers would notify patients that their prescriptions could be filled by a different pharmacy and provide Carter’s name to the patient. Third, Brothers would transfer the prescription and ship the prescribed product to Carter.1 Finally,

Carter would then deliver the product to the patient. Id. Pursuant to the Agreement, Brothers was also responsible for monitoring patient treatment. Id. at ¶ 8. Pursuant to the Agreement, Carter agreed to pay Brothers amounts invoiced to

1In the Agreement, “Product” is defined as blood factor and immunoglobulin products listed in Schedule A attached thereto. Dkt. No. 1-1 at 1, 3, 18. Carter for products and Brothers agreed to pay Carter a fixed fee. Id. at ¶ 9. The parties also agreed that, during the term of the Agreement and for one year

thereafter, no party would employ or retain as an independent contractor any person who was, at any time during the immediately preceding 12-month period, employed by or under contract with the other party. Id. at ¶ 10; Pharmacy Wholesale

Distribution & Shared Pharmacy Services Patient Care Coordination Agreement at ¶ 20.1, Dkt. No. 1-1. In 2021, Carter began to violate the express and implied terms of the Agreement. Compl. at ¶ 12. According to the Complaint, Carter did so by (1)

hiring a former Brothers employee, (2) refusing to pay Brothers amounts invoiced, (3) claiming that patients referred by Brothers were the patients of Carter, and (4) “[s]oliciting” Brothers’ patients so as to induce them to become patients of Carter.

Id. PROCEDURAL BACKGROUND Brothers initiated this action with the filing of the Complaint on September 13, 2021. Dkt. No. 1. Therein, it asserted the following five claims under State

law against Defendant Carter: (1) breach of contract; (2) breach of the implied covenant of good faith and fair dealing; (3) unfair competition; (4) interference with prospective economic advantage; and (5) unjust enrichment. After answering the Complaint, Dkt. No. 10, on May 14, 2022, Carter filed the instant motion for judgment on the pleadings (“motion”), Dkt. No. 28.2

Brothers filed a response to the motion, Dkt. No. 32, to which Carter replied, Dkt. No. 33. This Order follows. STANDARD OF REVIEW

Federal Rule of Civil Procedure 12(c) provides that, “[a]fter the pleadings are closed…a party may move for judgment on the pleadings.” The standard governing a Rule 12(c) motion is “functionally identical” to that governing a Rule 12(b)(6) motion. United States ex rel. Cafasso v. Gen. Dynamics C4 Sys., Inc., 637

F.3d 1047, 1054 n.4 (9th Cir. 2011). Federal Rule of Civil Procedure 12(b)(6) authorizes the Court to dismiss a complaint that fails “to state a claim upon which relief can be granted.” Rule

12(b)(6) is read in conjunction with Rule 8(a), which requires “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed.R.Civ.P. 8(a)(2). Pursuant to Iqbal, “[t]o survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is

plausible on its face.’” 556 U.S. at 678 (quoting Twombly, 550 U.S. at 570). In addition, “the tenet that a court must accept as true all of the allegations contained in

2Defendant had filed an earlier motion for judgment on the pleadings, Dkt. No. 20, but that motion was denied without prejudice for failure to comply with the requirement of Local Rule 7.8 to discuss the substance of the motion with opposing counsel before filing the same, Dkt. No. 27. a complaint is inapplicable to legal conclusions.” Id. Accordingly, “[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory

statements, do not suffice.” Id. (citing Twombly, 550 U.S. at 555). Rather, “[a] claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct

alleged.” Id. (citing Twombly, 550 U.S. at 556). Factual allegations that only permit the court to infer “the mere possibility of misconduct” do not show that the pleader is entitled to relief as required by Rule 8(a)(2). Id. at 679. When a complaint fails to state a plausible claim, leave to amend should be

given when “justice so requires.” Fed.R.Civ.P. 15(a)(2). Justice does not require leave to amend when (1) it would prejudice an opposing party, (2) it is sought in bad faith, (3) it would produce an undue delay in litigation, (4) it would be futile, or (5)

there has been repeated failure to cure a deficiency. Abagninin v. AMVAC Chem. Corp., 545 F.3d 733, 742 (9th Cir. 2008); AmerisourceBergen Corp. v. Dialysist West, Inc., 465 F.3d 946, 951 (9th Cir. 2006). DISCUSSION

Free access — add to your briefcase to read the full text and ask questions with AI

Brothers Healthcare, Inc. v. Brian Carter, Inc., (D. Haw. 2022).

Brothers Healthcare, Inc. v. Brian Carter, Inc. (Brothers Healthcare, Inc. v. Brian Carter, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Cafasso v. General Dynamics C4 Systems, Inc.
637 F.3d 1047 (Ninth Circuit, 2011)
Michael Lacey v. Joseph Arpaio
693 F.3d 896 (Ninth Circuit, 2012)
Hawaii Leasing v. Klein
698 P.2d 309 (Hawaii Intermediate Court of Appeals, 1985)
Abagninin v. Amvac Chemical Corp.
545 F.3d 733 (Ninth Circuit, 2008)
Best Place, Inc. v. Penn America Insurance Co.
920 P.2d 334 (Hawaii Supreme Court, 1996)
Durette v. Aloha Plastic Recycling, Inc.
100 P.3d 60 (Hawaii Supreme Court, 2004)
Calipjo v. Purdy.
439 P.3d 218 (Hawaii Supreme Court, 2019)
Hawaii Medical Ass'n v. Hawaii Medical Service Ass'n
148 P.3d 1179 (Hawaii Supreme Court, 2006)